Cargando…

The role of liver resection in metastatic nephroblastoma: a systematic review and Meta-regression analysis

BACKGROUND: The impact of hepatic resection for liver metastases (LM) on the survival of pediatric patients with Wilms’ tumor (WT) is unclear. So far, there is a lack of studies investigating the best suited treatment for patients with WTLM, and the role of liver resection has rarely been investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Juri, Murtha-Lemekhova, Anastasia, Kessler, Markus, Günther, Patrick, Hoffmann, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764777/
https://www.ncbi.nlm.nih.gov/pubmed/35038991
http://dx.doi.org/10.1186/s12885-022-09182-3
_version_ 1784634232975392768
author Fuchs, Juri
Murtha-Lemekhova, Anastasia
Kessler, Markus
Günther, Patrick
Hoffmann, Katrin
author_facet Fuchs, Juri
Murtha-Lemekhova, Anastasia
Kessler, Markus
Günther, Patrick
Hoffmann, Katrin
author_sort Fuchs, Juri
collection PubMed
description BACKGROUND: The impact of hepatic resection for liver metastases (LM) on the survival of pediatric patients with Wilms’ tumor (WT) is unclear. So far, there is a lack of studies investigating the best suited treatment for patients with WTLM, and the role of liver resection has rarely been investigated. Thus, the development of evidence-based guidelines concerning indications of liver resection for WTLM remains difficult. AIM: To investigate the role of surgery in the therapy of WTLM. All available data on liver resections and subgroup outcomes of patients with WTLM are analyzed. Main research question is whether liver resection improves survival rates of patients with WTLM compared to non-surgical treatment. METHODS: A systematic literature search of MEDLINE, Web of Science, and Central provided the basis for this PRISMA-compliant systematic review. For the main analysis (I), all studies reporting on surgical treatment of pediatric WTLM were included. To provide a representative overview of the general outcome of WTLM patients, in analysis II all studies with cohorts of at least five WTLM patients, regardless of the kind of treatment, were reviewed and analyzed. A Multiple meta-regression model was applied to investigate the impact liver resection on overall survival. RESULTS: 14 studies with reports of liver resection for WTLM were found (Analysis I). They included a total of 212 patients with WTLM, of which 93 underwent a liver resection. Most studies had a high risk of bias, and the quality was heterogenous. For the analysis II, eight studies with subgroups of at least five WTLM patients were found. The weighted mean overall survival (OS) of WTLM patients across the studies was 55% (SD 29). A higher rate of liver resection was a significant predictor of better OS in a multiple meta-regression model with 4 covariates (I2 29.43, coefficient 0.819, p = 0.038). CONCLUSIONS: This is the first systematic review on WTLM. Given a lack of suited studies that specifically investigated WTLM, ecological bias was high in our analyses. Generating evidence is complicated in rare pediatric conditions and this study must be viewed in this context. Meta-regression analyses suggest that liver resection may improve survival of patients with WTLM compared to non-surgical treatment. Especially patients with persisting disease after neoadjuvant chemotherapy but also patients with metachronous LM seem to benefit from resection. Complete resection of LM is vital to achieve higher OS. Studies that prospectively investigate the impact of surgery on survival compared to non-surgical treatment for WTLM are highly needed to further close the current evidence gap. STUDY REGISTRATION: PROSPERO 2021 CRD42021249763 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=249763. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09182-3.
format Online
Article
Text
id pubmed-8764777
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87647772022-01-18 The role of liver resection in metastatic nephroblastoma: a systematic review and Meta-regression analysis Fuchs, Juri Murtha-Lemekhova, Anastasia Kessler, Markus Günther, Patrick Hoffmann, Katrin BMC Cancer Research BACKGROUND: The impact of hepatic resection for liver metastases (LM) on the survival of pediatric patients with Wilms’ tumor (WT) is unclear. So far, there is a lack of studies investigating the best suited treatment for patients with WTLM, and the role of liver resection has rarely been investigated. Thus, the development of evidence-based guidelines concerning indications of liver resection for WTLM remains difficult. AIM: To investigate the role of surgery in the therapy of WTLM. All available data on liver resections and subgroup outcomes of patients with WTLM are analyzed. Main research question is whether liver resection improves survival rates of patients with WTLM compared to non-surgical treatment. METHODS: A systematic literature search of MEDLINE, Web of Science, and Central provided the basis for this PRISMA-compliant systematic review. For the main analysis (I), all studies reporting on surgical treatment of pediatric WTLM were included. To provide a representative overview of the general outcome of WTLM patients, in analysis II all studies with cohorts of at least five WTLM patients, regardless of the kind of treatment, were reviewed and analyzed. A Multiple meta-regression model was applied to investigate the impact liver resection on overall survival. RESULTS: 14 studies with reports of liver resection for WTLM were found (Analysis I). They included a total of 212 patients with WTLM, of which 93 underwent a liver resection. Most studies had a high risk of bias, and the quality was heterogenous. For the analysis II, eight studies with subgroups of at least five WTLM patients were found. The weighted mean overall survival (OS) of WTLM patients across the studies was 55% (SD 29). A higher rate of liver resection was a significant predictor of better OS in a multiple meta-regression model with 4 covariates (I2 29.43, coefficient 0.819, p = 0.038). CONCLUSIONS: This is the first systematic review on WTLM. Given a lack of suited studies that specifically investigated WTLM, ecological bias was high in our analyses. Generating evidence is complicated in rare pediatric conditions and this study must be viewed in this context. Meta-regression analyses suggest that liver resection may improve survival of patients with WTLM compared to non-surgical treatment. Especially patients with persisting disease after neoadjuvant chemotherapy but also patients with metachronous LM seem to benefit from resection. Complete resection of LM is vital to achieve higher OS. Studies that prospectively investigate the impact of surgery on survival compared to non-surgical treatment for WTLM are highly needed to further close the current evidence gap. STUDY REGISTRATION: PROSPERO 2021 CRD42021249763 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=249763. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09182-3. BioMed Central 2022-01-18 /pmc/articles/PMC8764777/ /pubmed/35038991 http://dx.doi.org/10.1186/s12885-022-09182-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fuchs, Juri
Murtha-Lemekhova, Anastasia
Kessler, Markus
Günther, Patrick
Hoffmann, Katrin
The role of liver resection in metastatic nephroblastoma: a systematic review and Meta-regression analysis
title The role of liver resection in metastatic nephroblastoma: a systematic review and Meta-regression analysis
title_full The role of liver resection in metastatic nephroblastoma: a systematic review and Meta-regression analysis
title_fullStr The role of liver resection in metastatic nephroblastoma: a systematic review and Meta-regression analysis
title_full_unstemmed The role of liver resection in metastatic nephroblastoma: a systematic review and Meta-regression analysis
title_short The role of liver resection in metastatic nephroblastoma: a systematic review and Meta-regression analysis
title_sort role of liver resection in metastatic nephroblastoma: a systematic review and meta-regression analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764777/
https://www.ncbi.nlm.nih.gov/pubmed/35038991
http://dx.doi.org/10.1186/s12885-022-09182-3
work_keys_str_mv AT fuchsjuri theroleofliverresectioninmetastaticnephroblastomaasystematicreviewandmetaregressionanalysis
AT murthalemekhovaanastasia theroleofliverresectioninmetastaticnephroblastomaasystematicreviewandmetaregressionanalysis
AT kesslermarkus theroleofliverresectioninmetastaticnephroblastomaasystematicreviewandmetaregressionanalysis
AT guntherpatrick theroleofliverresectioninmetastaticnephroblastomaasystematicreviewandmetaregressionanalysis
AT hoffmannkatrin theroleofliverresectioninmetastaticnephroblastomaasystematicreviewandmetaregressionanalysis
AT fuchsjuri roleofliverresectioninmetastaticnephroblastomaasystematicreviewandmetaregressionanalysis
AT murthalemekhovaanastasia roleofliverresectioninmetastaticnephroblastomaasystematicreviewandmetaregressionanalysis
AT kesslermarkus roleofliverresectioninmetastaticnephroblastomaasystematicreviewandmetaregressionanalysis
AT guntherpatrick roleofliverresectioninmetastaticnephroblastomaasystematicreviewandmetaregressionanalysis
AT hoffmannkatrin roleofliverresectioninmetastaticnephroblastomaasystematicreviewandmetaregressionanalysis